#

Search

Blog


<< Go Back
WINDLAS BIOTECH

Dividend - 4 Q4FY23 – Performance YoY Rev at 140Cr vs 122Cr ⬆️14% QoQ Rev at 140Cr Vs 119Cr ⬆️17% Year ended Rev: 513Cr Vs 465Cr ⬆10% YoY PAT at 11Cr vs 14Cr ⬇️21% QoQ PAT at 11Cr Vs 9Cr ⬆️9% Year ended PAT: 42Cr Vs. 38Cr ⬆️10% Q3EPS at 5.37Rs vs 6.97Rs Vs.4.23Rs Year ended EPS: 19.70 Vs. 18.58